Francesc Bosch is Professor of Hematology, Head of the Department of Hematology in University Hospital Vall d’Hebron, Barcelona, and Head of the Department of Hematology in IOB Institute of Oncology. Professor Bosch graduated from Medical School in the University of Barcelona 1988. In 1997 he was awarded a PhD by the University of Barcelona for his research about the over-expression of Cyclin D1 in chronic lymphoproliferative disorders under the supervision of Professor Elias Campo. He subsequently did a two-year postdoctoral stay in the laboratory of Professor Riccardo Dalla-Favera at the Institute of Cancer Genetics, Columbia University, New York. He moved back to Hospital Clinic in Barcelona in 2000 where he continued doing research in CLL. In September 2009, Prof Bosch became Head of the Department of Hematology and Director of the Experimental Hematology Laboratory at the University Hospital Vall d’Hebron in Barcelona. Professor Bosch conducts both clinical and basic research in CLL and other lymphoproliferative disorders, particularly focusing in the molecular pathogenesis of CLL and in the development of novel therapeutic approaches. Professor Bosch is currently chairing the Spanish CLL Working Group (GELLC), responsible for the development of Spanish CLL Clinical trials. He has published more than 200 papers in many peer-reviewed journals. In addition, he has (co-)authored several reviews and book chapters on CLL and other lymphoproliferative disorders.
EM-73214 - Date of preparation: September 2021